European shares extend rally on vaccine cheer
Reuters
Published Nov 11, 2020 08:19
(Reuters) - European shares rose for a third straight session on Wednesday as optimism around a COVID-19 vaccine overshadowed concerns about the economic damage from a second wave of coronavirus infections across the continent.
The pan-European STOXX 600 (STOXX) gained 0.4%, building on a 5% rally this week, as investors bought into banks (SX7P) and travel-related stocks (SXTP), both sectors that have widely underperformed this year.
Technology stocks (SX8P), which have tracked a surge in their U.S. counterparts since the coronavirus-driven crash in March, fell 0.5%.
Dutch bank ABN Amro (AS:ABNd) dropped 3.4% even after it beat analysts' expectations, while German auto supplier Continental (DE:CONG) slid 1.6% as it warned of further restructuring expenses in the fourth quarter.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.